Cavagna FM - Search Results

1

Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.

de Haën C, Anelli PL, Lorusso V, Morisetti A, Maggioni F, Zheng J, Uggeri F, Cavagna FM. de Haën C, et al. Among authors: cavagna fm. Invest Radiol. 2006 Mar;41(3):279-91. doi: 10.1097/01.rli.0000195848.17065.13. Invest Radiol. 2006. PMID: 16481911

2

Comparison of gradient-echo and steady-state free precession for coronary artery magnetic resonance angiography using a gadolinium-based intravascular contrast agent.

Deshpande VS, Cavagna F, Maggioni F, Schirf BE, Omary RA, Li D. Deshpande VS, et al. Invest Radiol. 2006 Mar;41(3):292-8. doi: 10.1097/01.rli.0000186566.38619.6d. Invest Radiol. 2006. PMID: 16481912

3

Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI.

Cavagna FM, Lorusso V, Anelli PL, Maggioni F, de Haën C. Cavagna FM, et al. Acad Radiol. 2002 Aug;9 Suppl 2:S491-4. doi: 10.1016/s1076-6332(03)80273-8. Acad Radiol. 2002. PMID: 12188318 No abstract available.

4

Single-session magnetic resonance coronary angiography and myocardial perfusion imaging using the new blood pool compound B-22956 (gadocoletic acid): initial experience in a porcine model of coronary artery disease.

Zheng J, Li D, Maggioni F, Abendschein D, Simonetti O, Laub G, Finn JP, Gropler RJ, Cavagna FM. Zheng J, et al. Among authors: cavagna fm. Invest Radiol. 2005 Sep;40(9):604-13. doi: 10.1097/01.rli.0000174578.51744.7d. Invest Radiol. 2005. PMID: 16118554

5

B22956/1, a new intravascular contrast agent for MRI: first administration to humans--preliminary results.

La Noce A, Stoelben S, Scheffler K, Hennig J, Lenz HM, La Ferla R, Lorusso V, Maggioni F, Cavagna F. La Noce A, et al. Acad Radiol. 2002 Aug;9 Suppl 2:S404-6. doi: 10.1016/s1076-6332(03)80245-3. Acad Radiol. 2002. PMID: 12188290 Clinical Trial. No abstract available.

6

Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.

Cavagna FM, Maggioni F, Castelli PM, Daprà M, Imperatori LG, Lorusso V, Jenkins BG. Cavagna FM, et al. Invest Radiol. 1997 Dec;32(12):780-96. doi: 10.1097/00004424-199712000-00009. Invest Radiol. 1997. PMID: 9406019

7

Gd-BOPTA/Dimeg: experimental disease imaging.

Cavagna F, Daprà M, Maggioni F, de Haën C, Felder E. Cavagna F, et al. Magn Reson Med. 1991 Dec;22(2):329-33; discussion 343-6. doi: 10.1002/mrm.1910220235. Magn Reson Med. 1991. PMID: 1812366

8

Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts.

Cavagna FM, Marzola P, Daprà M, Maggioni F, Vicinanza E, Castelli PM, de Haën C, Luchinat C, Wendland MF, Saeed M, et al. Cavagna FM, et al. Invest Radiol. 1994 Jun;29 Suppl 2:S50-3. doi: 10.1097/00004424-199406001-00018. Invest Radiol. 1994. PMID: 7928270 No abstract available.

9

Evaluation of the hepatocyte-specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model.

Marzola P, Maggioni F, Vicinanza E, Daprà M, Cavagna FM. Marzola P, et al. Among authors: cavagna fm. J Magn Reson Imaging. 1997 Jan-Feb;7(1):147-52. doi: 10.1002/jmri.1880070121. J Magn Reson Imaging. 1997. PMID: 9039606

10

Trends and developments in MRI contrast agent research.

Cavagna FM, Daprà M, Castelli PM, Maggioni F, Kirchin MA. Cavagna FM, et al. Eur Radiol. 1997;7 Suppl 5:222-4. doi: 10.1007/pl00006896. Eur Radiol. 1997. PMID: 9370547 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page